Skip to Content

Hatchpak Cocci III (Canada)

This page contains information on Hatchpak Cocci III for veterinary use.
The information provided typically includes the following:
  • Hatchpak Cocci III Indications
  • Warnings and cautions for Hatchpak Cocci III
  • Direction and dosage information for Hatchpak Cocci III

Hatchpak Cocci III

This treatment applies to the following species:
Manufacturer: Merial


Live Oocysts

This vaccine contains the oocysts of Eimeria maxima, Eimeria acervulina, and Eimeria tenella and has shown to aid in the prevention of Coccidiosis. The product is recommended for the initial vaccination of healthy chickens one-day of age or older by spray.

Hatchpak Cocci III Caution

Do not freeze.

Administer only as recommended.

Use entire contents when first opened.

Do not vaccinate within 21 days of slaughter.

Burn this container and all unused contents.

Storage Conditions

Store at 2-7°C. Do not freeze.

Hatchpak Cocci III Indications

This vaccine is recommended for the vaccination of healthy chickens as an aid in the prevention of Coccidiosis. It is essential that the chickens be maintained under good environmental conditions that include moisture for sporulation and free access to fecal droppings.

Exposure to other disease agents should be reduced as much as possible.


1. Do not open vaccine vial until ready to vaccinate.

2. Reconstitute vaccine at a rate of 21 to 30 mL per 100 chickens using non-chlorinated water.

3. Each box of 100 chickens should receive approximately 21 to 30 mL of vaccine based on the dilution rate used.


Do not vaccinate diseased chickens.

Vaccinate all chickens on the premises at one time.

Administer a minimum of one dose per chicken.

Avoid stress conditions during and following vaccination.

Do not place chickens in contaminated facilities

Exposure to disease must be minimized as much as possible.

For veterinary use only.

This vaccine is not recommended for use on chicks receiving a feed containing a coccidiostat or high levels of antibiotic.

Following vaccination, it may be necessary to use drugs for treatment of disease conditions other than coccidiosis. If such drugs, with a coccidiostat activity, are used during the first or second week post-vaccination of Merial’s Coccidiosis Vaccine, revaccination is recommended.


Merial’s vaccines have met the requirements of the USDA/CFIA in regard to safety, purity and potency.

Hatchpak Cocci III Caution

The capability of this vaccine to produce satisfactory results depends upon many factors including - but not limited to - conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of individual chickens and degree of field exposure. Therefore, directions for use should be followed carefully. The use of this vaccine is subject to applicable local and federal laws and regulations.


MERIAL, INC., Athens, GA 30601 USA

U.S. Vet. License No. 298

Product Codes COXY305K, COXY310K, COXY320K



Presentation: 10 x 10,000 doses.

CPN: 1182155.0

Every effort has been made to ensure the accuracy of the Hatchpak Cocci III information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the product label or package insert.

Copyright © 2017 North American Compendiums. Updated: 2017-04-21